more

Client Profile

Renovo Neural, Inc.

Renovo Neural is a drug discovery company involved in development of proprietary small molecule pharmaceutical candidates that can provide complementary therapeutics for neuro-immunomodulation market. In addition, Renovo is creating a niche of specialty services that can revolutionize development of therapies for neural diseases, specifically multiple sclerosis.

CEO
Satish Medicetty
Type of Business
Biotechnology
Number of Employees
9
Recent Successes
Renovo on cutting edge of cure for MS.